Company / Total Assets
Korro Bio, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$113.5M
FY2025
5-year range
$113.5M / $264.7M
FY2021-FY2025
Trend
-49.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 6 years, ranging from $114M in FY2025 to $265M in FY2020.
Based on SEC 10-K filings.
$114M in FY2025 with a 5-year CAGR of -15.6%.
Declined from $121M to $114M over the past 3 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- -15.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.6%, indicating a declining trend.
- In FY2025, total assets decreased 49.8% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.5M | -49.8% |
| FY2024 | $226.2M | +86.6% |
| FY2022 | $121.2M | -34.6% |
| FY2021 | $185.4M | -30.0% |
| FY2020 | $264.7M | +18.6% |
| FY2019 | $223.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026